Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.0.1500779
European Journal of Endocrinology, Vol 150, Issue 6, 779-787
Copyright © 2004 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Norrelund, H
Right arrow Articles by Moller, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Norrelund, H
Right arrow Articles by Moller, N
Articles

Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting

H Norrelund, S Nielsen, JS Christiansen, JO Jorgensen, and N Moller

Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital, DK-8000 Aarhus C, Denmark. helenenorrelund@dadlnet.dk

BACKGROUND AND AIMS: The metabolic response to fasting involves an increase in circulating levels of growth hormone (GH) and free fatty acids, and resistance to insulin's actions on glucose metabolism. Stimulation of lipolysis and insulin resistance are well-described effects of GH. The present study was designed to test the degree to which the insulin antagonistic effects of GH on glucose metabolism are mediated through stimulation of lipolysis during fasting. METHODS: Seven normal subjects were examined on three occasions during a 40-h fast with infusion of somatostatin, insulin and glucagon for the final 18 h: (expt. i) with GH replacement, (expt. ii) with GH replacement and antilipolysis with acipimox, and (expt. iii) without GH and with antilipolysis. RESULTS: Basal glucose turnover was significantly reduced by addition of acipimox (rate of disappearance (Rd) glucose (mg/kg/min): 1.91+/-0.08 (expt. i), 1.69+/-0.05 (expt. ii), 1.61+/-0.08 (expt. iii); P<0.01), whereas insulin-stimulated glucose uptake was significantly increased (glucose infusion rate (M-value) (mg/kg/min): 1.66+/-0.22 (expt. i), 2.47+/-0.10 (expt. ii), 2.00+/-0.31 (expt. iii); P<0.05). Addition of GH during inhibition of lipolysis failed to affect basal and insulin-stimulated glucose metabolism significantly. CONCLUSION: Thus, the present data provide strong evidence that the insulin antagonistic effects of GH on fasting glucose metabolism are causally linked to concomitant stimulation of lipolysis.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
M. R. Soeters, H. P. Sauerwein, J. E. Groener, J. M. Aerts, M. T. Ackermans, J. F. C. Glatz, E. Fliers, and M. J. Serlie
Gender-Related Differences in the Metabolic Response to Fasting
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3646 - 3652.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. H. Vickers, P. L. Hofman, P. D. Gluckman, P. E. Lobie, and W. S. Cutfield
Combination therapy with acipimox enhances the effect of growth hormone treatment on linear body growth in the normal and small-for-gestational-age rat
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1212 - E1219.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
L. J. Woodhouse, A. Mukherjee, S. M. Shalet, and S. Ezzat
The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults
Endocr. Rev., May 1, 2006; 27(3): 287 - 317.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 European Society of Endocrinology.